Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cellsin vitroandin vivo
Authors:
Open Access
- 31 May 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (26) , 40398-40417
Abstract
Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivoKeywords
This publication has 29 references indexed in Scilit:
- Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitorsOncoTargets and Therapy, 2016
- Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cellsOncotarget, 2016
- Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone functionOncotarget, 2016
- Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cellsOncotarget, 2015
- PTEN–PDZ domain interactions: Binding of PTEN to PDZ domains of PTPN13Methods, 2015
- HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphomaBlood, 2015
- Nexavar/Stivarga and Viagra Interact to Kill Tumor CellsJournal of Cellular Physiology, 2015
- Regulation of OSU-03012 Toxicity by ER Stress Proteins and ER Stress–Inducing DrugsMolecular Cancer Therapeutics, 2014
- OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killingCancer Biology & Therapy, 2012
- H-RAS V12–induced radioresistance in HCT116 colon carcinoma cells is heregulin dependentMolecular Cancer Therapeutics, 2005